Remarkably, this combined formulation was shown to increase specificity towards cancer cells, promoting apoptosis via reduction in Bcl-2 and upregulation of p53 while enhancing PARP cleavage and γ-H2AX activation [83]. The gene discussed is TP53; the disease is cancer.